Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-FU and PDT for Actinic Keratosis in Transplant Recipients
NCT01525329Phase 3Terminated
- Sponsor
- Cleveland Clinic
- Start
- Sep 2011
- Primary completion
- Nov 2016
- Countries
- 1
01
Overview
A Phase 3 trial of fluorouracil 5% cream in actinic keratosis (AK), sponsored by Cleveland Clinic. Started Sep 2011; status: terminated.
02
Drugs
fluorouracil 5% cream
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01525329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01525329.